Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on February 15, 2001, Cedarburg Phamaceuticals, LLC, 870 Badger Circle, Grafton, Wisconsin 53024, made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of tetrahydrocannabinols (7370), a basic class of controlled substance listed in Schedule I.
The firm will manufacture tetrahydrocannabinols for another firm.
Any other such applicant and any person who is presently registered with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than October 29, 2001.Start Signature
Dated: August 20, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of diversion Control, Drug Enforcement Administration.
[FR Doc. 01-21716 Filed 8-27-01; 8:45 am]
BILLING CODE 4410-09-M